Recent Company News

• 07:36 PM ET Apr 29, 2025
  

  Starpharma Holdings reports Q3 net cash from / (used in) operating activities (A$2.7M) - Appendix 4C (A$0.09, 0.00)

• 05:46 PM ET Feb 25, 2025
  

  Starpharma Holdings reports H1 adjusted NPAT (A$5.4M) vs year-ago (A$7.6M) - Appendix 4D (A$0.12, 0.00)

• 07:38 PM ET Dec 17, 2024
  

  StreetAccount Summary - Australia unusual volume traders

• 06:20 PM ET Jan 28, 2025
  

  Starpharma Holdings reports Q2 net cash from / (used in) operating activities (A$3.1M) - Appendix 4C (A$0.11, 0.00)

• 07:43 PM ET Dec 03, 2024
  

  StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday

• 05:49 PM ET Dec 18, 2024
  

  FDA provides positive feedback on Starpharma's proposed clinical development plan for DEP SN38 (A$0.10, 0.00)

• 07:18 PM ET Nov 20, 2024
  

  Starpharma Holdings shares DEP SN38 scientific poster that was presented at AGITG (A$0.11, +0.01)